Table 1.
Vital signsa | No. | % | Blood chemistry | No. | % | |
---|---|---|---|---|---|---|
RR (breaths/minute) | ALT (IU/L) (NR: 5-39) | |||||
≤19 | 41 | 42.7 | ≤39 | 74 | 76.3 | |
20-29 | 39 | 40.6 | 40-79 | 15 | 15.5 | |
30-39 | 16 | 16.7 | 80-199 | 5 | 5.2 | |
Total | 96 | 100.0 | 200≤ | 3 | 3.1 | |
SBP (mmHg) | Total | 97 | 100.0 | |||
≤89 | 5 | 5.1 | Cr (mg/dL) (NR: 0.40-0.99) | |||
90-139 | 75 | 76.5 | ≤0.99 | 83 | 86.4 | |
140-179 | 18 | 18.4 | 1.00-1.29 | 11 | 11.5 | |
Total | 98 | 100.0 | 1.30≤ | 2 | 2.1 | |
HR (beats/minute) | Total | 96 | 100.0 | |||
≤59 | 1 | 1.0 | CK (IU/L) (NR: 20-199) | |||
60-99 | 39 | 39.8 | ≤199 | 55 | 58.5 | |
100-139 | 47 | 48.0 | 200-1,999 | 32 | 34.0 | |
140≤ | 11 | 11.2 | 2,000-9,999 | 6 | 6.4 | |
Total | 98 | 100.0 | 10,000≤ | 1 | 1.1 | |
GCS | Total | 94 | 100.0 | |||
3-8 | 4 | 4.1 | Glucose (mg/dL) (NR: 70-109) | |||
9-14 | 32 | 32.7 | 70-109 | 7 | 7.7 | |
15 | 62 | 63.3 | 110-179 | 41 | 45.1 | |
Total | 98 | 100.0 | 180≤ | 43 | 47.3 | |
BT (oC) | Total | 91 | 100.0 | |||
≤34.9 | 6 | 6.4 | K+(mmol/L) (NR: 3.5-4.9) | |||
35.0-37.4 | 83 | 88.3 | ≤2.4 | 17 | 17.5 | |
37.5-38.4 | 4 | 4.3 | 2.5-3.4 | 65 | 67.0 | |
38.5≤ | 1 | 1.1 | 3.5-4.9 | 12 | 12.4 | |
Total | 94 | 100.0 | 5.0≤ | 3 | 3.1 | |
Total | 97 | 100.0 | ||||
IP (mg/dL) (NR: 2.5-4.9) | ||||||
≤1.4 | 10 | 21.7 | ||||
1.5-2.4 | 17 | 37.0 | ||||
2.5-4.9 | 15 | 32.6 | ||||
5.0≤ | 4 | 8.7 | ||||
Total | 46 | 100.0 | ||||
Lactate (mmol/L) (NR: 0.5-1.9) | ||||||
≤1.9 | 49 | 66.2 | ||||
2.0-3.9 | 8 | 10.8 | ||||
4.0≤ | 17 | 23.0 | ||||
Total | 74 | 100.0 |
aVital signs of two cardiopulmonary-arrested patients on admission were excluded. RR: respiratory rate, SBP: systolic blood pressure, HR: heart rate, GCS: Glasgow Coma Scale, BT: body temperature, ALT: alanine aminotransferase, Cr: creatinine, CK: creatine kinase, IP: inorganic phosphate, NR: normal range